at a Glance
Alfresa Group’s overview for your quick understanding
The name “Alfresa” combines
the English word “all” with
the Esperanto word “fresa,” which means “fresh.”
- Ethical Pharmaceuticals Wholesaling Business
- Self-Medication Products Wholesaling Business
- Manufacturing Business
- Medical-Related Business
- Information System Business for the Alfresa Group
The Realization of a Healthcare Consortium
“Realization of a Healthcare Consortium” means the establishment of a system that can contribute to people’s lives and health by forming alliances not only with Group companies but also with other firms in the healthcare business to offer comprehensive medical care and healthcare information, products and services. We has been reforming the business model and proceeding initiatives in various fields.
Alfresa Group’s Data
Group Management Results
Operating Income Margin0.79%
Profit Margin Attribute to
Owners of the Parent0.94%
Total Assets1,316.6billion yen
Owner’s Equity Ratio37.2%
Return on Equity5.1%
Earnings per Share115.75yen
Dividend on Equity Ratio2.3%
Total Shareholder Return109.3%
●The figures shown are as of March, 2021.
※Source: “2021 ALL DATA & RANKING” published by Drugmagazine Co., Ltd.
Alfresa Group’s Strength
Robust distribution system
We are effectively positioning our distribution centers with high processing capabilities and building a distribution platform that meets the needs of customers such as hospitals, dispensing pharmacies, and drugstores through a nationwide network of branches and offices.
Relationships of trust with customers and suppliers
We have established a position as the No. 1 ethical pharmaceuticals wholesaler in net sales by building up wide-ranging transactions with pharmaceutical and medical equipment manufacturers, and strong relationships of trust with customers. We also aim to create new value by serving as a connection between medical care, nursing care, local government, and others.
Diversified business portfolio
We have built a supply chain that spans from manufacturing to wholesale and final delivery of medicine to patients at dispensing pharmacies. By utilizing this supply chain, we also operate a wide range of businesses including prevention of disease as well as treatment, diagnosis, and procedures. We will make further investments in growth businesses and seek to sustainably expand our business domains.
We will maximize synergies between each business segment, including development and manufacture of products that reflect customer needs picked up by the wholesaling business and other business, wholesaling of products manufactured in-house, and sales cooperation of over-the-counter (OTC) and health food products at dispensing pharmacies.
What We Value
The Alfresa Group
considers its valuable people
to be the true driver for sustainable growth into the future
To create and deliver a fresh life for all, we are working
to develop talent who flexibly respond to all medical needs,
have willingness to challenge and continue to grow.
Talent development strategies
- Reinforce OJT
- Realize career plans which expand growth opportunities
- Secure diverse personnel and have them play active roles
- Reform training programs